Filament Health Looks to , Natural Sources of Psychedelics , for a Number of Treatments.
'The Independent' reports that numerous startups have been looking to tap into mind-altering psychedelic drugs to treat a number of conditions, including depression.
Vancouver-based Filament Health's unique approach seeks to extract the drugs from natural sources, rather than synthesizing them in a laboratory.
Drugs like psilocybin and mescaline are extracted from mushrooms and cacti to be used as a treatment for opioid and stimulant use disorder.
Drugs like psilocybin and mescaline are extracted from mushrooms and cacti to be used as a treatment for opioid and stimulant use disorder.
Since our products come from natural sources, we believe it allows people to maintain a certain connection to how humans have been ingesting these substances for years and years and to important aspects of many traditional communities, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
Since our products come from natural sources, we believe it allows people to maintain a certain connection to how humans have been ingesting these substances for years and years and to important aspects of many traditional communities, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
'The Independent' reports that over a dozen other companies and academic groups have been using the company's drugs to treat depression and chronic pain.
'The Independent' reports that over a dozen other companies and academic groups have been using the company's drugs to treat depression and chronic pain.
A natural product contains much more than just one single active compound, right?
And so in the case of magic mushrooms, for instance, they contain much more than just psilocybin.
, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
They contain other compounds like psilocin and a dozen or more other active ingredients, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
Filament Health's CEO, Benjamin Lightburn, told the Associated Press that the idea could be compared to a cup of coffee, which contains much more than just caffeine.
.
It’s our hypothesis that the presence of these other compounds may contribute to differences or perhaps even improvements in the therapeutic potential of these complex natural mixtures, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
It’s our hypothesis that the presence of these other compounds may contribute to differences or perhaps even improvements in the therapeutic potential of these complex natural mixtures, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
After all, these substances did evolve in nature alongside humans, Benjamin Lightburn, Filament Health's CEO, via 'The Independent'
